| Literature DB >> 27531960 |
Pedro Fernandez-Funez1, Jonatan Sanchez-Garcia2, Lorena de Mena2, Yan Zhang2, Yona Levites3, Swati Khare2, Todd E Golde4, Diego E Rincon-Limas1.
Abstract
Alzheimer's disease (AD) is the most prevalent of a large group of related proteinopathies for which there is currently no cure. Here, we used Drosophila to explore a strategy to block Aβ42 neurotoxicity through engineering of the Heat shock protein 70 (Hsp70), a chaperone that has demonstrated neuroprotective activity against several intracellular amyloids. To target its protective activity against extracellular Aβ42, we added a signal peptide to Hsp70. This secreted form of Hsp70 (secHsp70) suppresses Aβ42 neurotoxicity in adult eyes, reduces cell death, protects the structural integrity of adult neurons, alleviates locomotor dysfunction, and extends lifespan. SecHsp70 binding to Aβ42 through its holdase domain is neuroprotective, but its ATPase activity is not required in the extracellular space. Thus, the holdase activity of secHsp70 masks Aβ42 neurotoxicity by promoting the accumulation of nontoxic aggregates. Combined with other approaches, this strategy may contribute to reduce the burden of AD and other extracellular proteinopathies.Entities:
Keywords: Drosophila; Hsp70; amyloid-β; engineered chaperones; neuroprotections
Mesh:
Substances:
Year: 2016 PMID: 27531960 PMCID: PMC5024614 DOI: 10.1073/pnas.1608045113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205